Sign in
4

Changes in Ownership

Design Therapeutics, Inc. Filed Acc 0001415889-25-021842

Director sold 562,627 shares at $5.25 ($2,953,792)

From the SEC's structured data for this filing

Trades in this filing

William Arsani · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-08-13 Sale : show line 1 in the form −345,000 $5.25 $1,811,250 2,655,000 I
2025-08-13 Sale : show line 2 in the form −217,627 $5.25 $1,142,542 1,000,000 I
Open-market sales · 562,627 sh · avg $5.25 · $2,953,792
Loading xslF345X05/form4-08142025_040805.xml…